Breaking News

MedArrive’s big pivot

August 27, 2024
Reporter, STAT Health Tech Writer

Good morning! As I continue examining preventive health tech products, I'm curious if anyone out there has had luck with direct-to-consumer lab tests. Why did you order them and what did you learn? (And thanks to those of you who reached out about your full-body MRI scans.)

Also, we're taking a brief summer break and will be off for the next two editions, but will be back to you after the Labor Day holiday with even more health tech news. 

As always, reach me at mohana.ravindranath@statnews.com.

research

Study: Can team-based notes slash EHR time?

A new large-scale study assessing team-based documentation strategies — like using medical scribes or co-authored notes — concludes that they increase clinicians' productivity and reduce time spent filling out electronic health records. It's an early attempt to quantify the impact new documentation approaches have on doctors, authors said in their JAMA Internal Medicine investigation.

The analysis covered more than 18,000 ambulatory doctors and their notes taken between September 2020 and April 2021. It revealed that team-based documentation was linked to a 6% increase in visits and a 4.1% decrease in EHR time. But doctors with less than 40% of notes co-authored by another team member didn't see any time saved, researchers wrote.


Artificial intelligence

A national AI registry could help increase transparency, experts say

Also on hospital IT, a group of AI experts is pushing for a national registry of AI tools that would lay out where and how products are being used, as well as how well they work, my colleague Casey Ross reports. It's meant to fill a potentially dangerous gap in AI monitoring, which is mostly conducted at individual health systems.

"Everybody is doing this differently, and many health systems are not doing it," Michael Pencina, chief data scientist at Duke Health, told Casey.

It's not an entirely new idea: There are already databases logging clinical algorithms and equations, for instance, and the White House pitched a similar idea in its AI blueprint last year.

But a crucial question is whether AI vendors will be on board. Many leading AI vendors and distributors, including Epic, Oracle Health and Microsoft, declined to comment or didn't respond to Casey's request for interviews on the topic.

"If I'm a developer of an algorithm that drifts and doesn't do well, I probably would not want to advertise it publicly," Pencina said. "I'd like to have that information first and try to fix it." Read more, and let me know if you think the idea has legs.


startups

MedArrive pivots away from in-home medical care

A health tech startup co-founded by former Lyft and Uber exec Dan Trigub is turning away from its original mission of home health care in search of a more viable and sustainable business, leaders told me earlier this week. Founded in 2018, MedArrive was initially focused on dispatching EMS professionals and other "physician-extenders" to patients' homes, where they'd connect to doctors via telehealth to treat patients who couldn't make it to in-person care. (The company used to partner with health plans and managed care groups like Centene.)

Now the company's wound down that practice and is focusing on building IT health care providers can use to make their own workforce more efficient, including scheduling and care coordination, Trigub and Tharika Chandrasekhar, who oversees operations and tech product management at MedArrive, told me.  While MedArrive's longitudinal home care programs helped Medicaid patients stay out of the emergency department (among other metrics), "the economics were very very difficult," Trigub said.

But leaders realized the company, which has raised $40 million in venture funding, had built some potentially valuable technology along the away that other providers could use, he explained. "We really saw a unique opportunity to really move away from just a service business."

For now, MedArrive is partnering with a set of health care providers to co-develop and refine the technology, and the goal is to commercialize it in the next year or so. "We definitely want to make sure we're proving value before we start charging for it," Chandrasekhar said.


whole body scans

Prenuvo tests out a mobile clinic in Buffalo, N.Y.

The Bay Area startup known for popularizing full-body scans — including among celebrities like Kim Kardashian — is trying a new tactic to reach patients for preventive imaging: Send a semi-truck outfitted with a body scanner around the country, beginning with Buffalo. Prenuvo, which was originally founded in Vancouver but now operates largely in the U.S., is also exploring the possibility of expanding into various Canadian provinces, but each one has its own regulations surrounding preventive services, founder Andrew Lacy told me. Located initially at the border of the U.S. and Canada, a mobile clinic could draw patients from up north, he said.

It's also an attempt to test-drive the viability of a mobile clinic that could eventually be dispatched across the country for a few months at a time, he said. "We wanted to make sure we understood, operationally, how to run this type of machine," he said.  "There are markets where there isn't quite yet enough local demand to justify what would otherwise be quite an expensive [permanent] clinic."

Prenuvo's biggest challenge, he said, is that "the level of awareness of preventive screening is still very low everywhere — it's low among consumers, it's low among physicians, it's low among the types of people that are decision-makers among provincial governments," he said.

Still, as STAT has reported, imaging experts and doctors disagree on the clinical value and potential downsides of elective preventive screening, especially those that aren't covered by insurance and can cost thousands of dollars out of pocket.


virtual care

Major drugmakers turn to telehealth for migraine care

This week my colleague Katie Palmer dives into the pharma world where she's seen growing interest in virtual care: Major drugmakers like Amgen, AbbVie and Eli Lilly are all promoting telehealth alongside their migraine drugs, for instance. And Pfizer climbed on the bandwagon today when it launched its own direct-to-consumer portal PfizerForAll, where it offers, among other services, an option to "talk to a doctor now" and get prescriptions filled through an online pharmacy. Read more on what it all means from Katie.



diabetes tech

Continuous glucose monitoring for the masses is here
The small devices measuring blood glucose by piercing the top layer of skin have, for decades, shaped diabetes care — and they're about to get much more accessible as companies like Dexcom and Abbott begin selling them over the counter without a prescription, Katie Palmer and Lizzy Lawrence write.

They're being marketed to millions of Americans: the almost 100 million with pre-diabetes, type 2 diabetes patients, and healthy people eager to track their own blood sugar levels. Manufacturers are also hoping the weight loss drug frenzy could boost interest in the devices.

But whether it'll take hold depends on how, and whether, clinicians and patients decide to use these trackers, Katie and Lizzy write. "You're looking at questions like affordability, how often patients are going to use this, whether they're actually going to change their behavior and keep using it," Marie Thibault, a medical technology and digital health analyst at finance firm BTIG, told STAT. Read more.


Type 2 diabetes patients can now automatically dose insulin

In other diabetes news, the Food and Drug Administration has cleared the first closed-loop insulin delivery system for type 2 diabetes patients, Lizzy and Katie tell us. (Type 1 diabetes patients have used the technology, made by Insulet, for years; over time, researchers started looking into whether the tech might benefit type 2 patients.)

The system connects glucose sensors to insulin pumps, which automatically dose out the drug based on the patient's blood sugar level. The goal is to reduce disease burden for type 2 patients, who previously relied on manual insulin injections and non-automated insulin pumps.

According to the FDA, the study supporting the device's clearance showed overall blood sugar control improvement among participants and reported no serious adverse events.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading


Thanks for reading! More on Thursday - Mohana

Mohana Ravindranath is a Bay Area correspondent covering health tech at STAT and has made it her mission to separate out hype from reality in health care.


Enjoying STAT Health Tech? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments